Genetic Technologies Limited (ASX:GTG)
Genetic Technologies Limited (ASX:GTG) is a diversified molecular diagnostics company. Genetic provides cancer predictive testing and assessment tools to help physicians proactively manage patient health.
The Company’s two lead products - GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer - are both clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products.